Fundraising Fox
Thabor Therapeutics
Rennes, FR · 1 known investors
Find your way into Thabor Therapeutics
Sign up to see every warm intro you have to Thabor Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Thabor Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Thabor Therapeutics is an INSERM spin-off developing a first-in-class therapeutic antibody targeting AGR2 for treating inflammatory mucosal diseases. The company focuses on immunology and therapeutic antibody development.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Thabor Therapeutics do?
- Thabor Therapeutics is an INSERM spin-off developing a first-in-class therapeutic antibody targeting AGR2 for treating inflammatory mucosal diseases. The company focuses on immunology and therapeutic antibody development.
- Who founded Thabor Therapeutics?
- Thabor Therapeutics was founded by Eric Chevet, Xavier Treton.
- Who are Thabor Therapeutics's investors?
- Thabor Therapeutics's investors include AdBio partners.
- Where is Thabor Therapeutics headquartered?
- Thabor Therapeutics is headquartered in Rennes, FR.